Surgery – Liquid medicament atomizer or sprayer
Reexamination Certificate
2005-08-30
2005-08-30
Leith, Patricia (Department: 1654)
Surgery
Liquid medicament atomizer or sprayer
C128S200240, C424S406000, C423S405000
Reexamination Certificate
active
06935334
ABSTRACT:
Methods for reducing, partially preventing or completely preventing nitric oxide (NO) inhalation-related impairment of HPV in a mammal are disclosed. The methods include administering a therapeutically effective amount of NO by inhalation, and co-administering an effective amount of an anti-reactive oxygen species (anti-ROS) agent, e.g., N-acetyl-cysteine, or a leukotriene blocker. Methods for reducing, partially preventing or completely preventing loss of pulmonary vasodilatory responsiveness to NO inhalation in a mammal are also disclosed. The methods include administering a therapeutically effective amount of NO by inhalation, and co-administering an effective amount of an anti-ROS agent a therapeutically effective amount of a leukotriene blocker.
REFERENCES:
patent: 5396882 (1995-03-01), Zapol
patent: 5427797 (1995-06-01), Frostell et al.
patent: 5485827 (1996-01-01), Zapol et al.
patent: 5570683 (1996-11-01), Zapol
patent: 5728705 (1998-03-01), Lawson et al.
patent: 5823180 (1998-10-01), Zapol
patent: 5885621 (1999-03-01), Head et al.
patent: 6063407 (2000-05-01), Zapol et al.
patent: 0 692 984 (1996-01-01), None
patent: WO 94/22306 (1994-10-01), None
patent: WO 99/37616 (1996-07-01), None
patent: WO 96/25184 (1996-08-01), None
patent: WO 96/39409 (1996-12-01), None
patent: WO 01/32202 (2001-05-01), None
patent: WO 01/45703 (2001-06-01), None
Baker et al., “Synthetic Combined Superoxide Dismutast/Catalase Mimetics are Protective as a Delayed Treatment in a Rat Stroke Model: A Key Role for Reactive Oxygen Species in Ischemic Brain Injury”Journal of Pharm and Exper. Thera., 284: 1 (1998).
Bigatello et al., “Prolonged Inhalation of Low Concentration of Nitric Oxide in Patients with Severe Adult Respiratory Distress Syndrome,”Anesthesiology80:761-770 (1994).
Charleson et al., “Structural Requirements for the Binding of Fatty Acids to 5-Lipoxygenase-Activating Protein”Eur. J. Pharmacol., 17: 267(3) PubMed Abstract (1994).
Dellinger et al., “Effects of Inhaled Nitric Oxide in Patients with Acute Respiratory Distress Syndrome: Results of a Randomized Phase II Trial,”Crit. Care Med.26: 15-23 (1998).
Foubert, et al., “Safety Guidelines for use of Nitric Oxide”,The Lancet, 339: 1615-1616 (1992).
Frostell et al., “Inhaled Nitric Oxide, A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction,”Circulation83:2038-2047 (1991).
Gauthier et al, “Stereospecific Synthesis, Assignment of Absolute Configuration, and Biological Activity of the Enantiomers of 3-[3-[2 -(7-3-Chloroquinolin-2-YL)-e)-Ethenyl]] [[3-Dimethylamino)-3-Oxypropyl]thio . . .”J. Med. Chem., 10: Pub Med (1990).
Gerlach et al., “Low Levels of Inhaled Nitric Oxide in Acute Lung Injury,”Nitric Oxide and the Lung(Zapol and Block, eds.). Marcel Dekker Inc., New York, 271-283.
Groves, et al., “Exogenous Nitric Oxide Inhibits in Vivo Platelet Adhesion Following Balloon Angioplasty”Cardiovasc Res26(6): 615-9 (Jun. 1992).
Hatzelmann et al, “Mode of Action of the New Selective Leukotriene Synthesis Inhibitor Bay X 1005 ((R-2-[4-9Quinolin-2-YL-Methoxy)Phenyl]-2-Cyclopentyl Acetic Acid) and Structurally Related Compounds”Biochem Phramcol., 45(1): PubMed Abstract (1993).
Högman, et al., “Prolonged Bleeding Time During Nitric Oxide Inhalation in the Rabbit”,Acta Physiol. Scand151: 125-129 (1994).
Holzmann et al., “Hyporesponsiveness to Inhaled Nitric Oxide in Isolated, Perfused Lungs from Endotoxin-Challenged Rats,”American Journal of Physiology271:L981-L986 (1996).
Holzmann et al., “Inhibition of Nitric-Oxide Synthase Prevents Hyporesponsiveness to Inhaled Nitric Oxide in Lungs from Endotoxin-Challenge Rats,”Anesthesiology91:215-221 (1999).
Hutchinson et al., “Effect of Endotoxemia on Hypoxic Pulmonary Vasoconstriction in Unanesthetized Sheep,”J. Appl. Physiol. 58: 1463-1468 (1985).
Ichinose et al., “Preserved Hypoxic Polmonary Vasoconstriction in 5-Lypoxygenase Deficient Mice,”Am. J. Respiratory and Critical Care Medicine161:A411 (abstr.).
Ignarro, L.J., “Endothelium-Derived Nitric Oxide: Actions and Properties”,The FASEB Journal3: 31-36 (1989).
Ignarro, L.J., “Endothelium-Derived Nitric Oxide: Pharmacology and Relationship to the Actions of Organic Nitrate Esters”,Pharmaceutical Research6: 8 651-659 (1989).
Jones et al. “Pharmacology of the Leukotriene Antagonist Verlukast: The (R) Enantiomer of MK-571”Can. J. Physiol. Pharmacol., 69(12): PubMed Abstract (1991).
Krafft et al., “Effectiveness of Nitric Oxide Inhalation in Septic ARDS,”Chest109:486-493 (1996).
Kusner et al. “The 5-Lipoxygenase Inhibitors ZD2138 and ZM230487 are Potent and Selective Inhibitors of Several Antigen-Induced Guinea-Pig Pulmonary Responses”Eur. J. Pharmacol., 257(3): PubMed Abstract (1994).
Manktelow et al., “Physiologic Determinants of the Response to Inhaled Nitric Oxide in Patients with Acute Respiratory Distress Syndrome,”Anesthesiology87:297-307.
Panin et al., “The Role of Hepatocytes and Kupffer's and Endothelial Liver Cells in Blood Lipoprotein Metabolism,”Biochemistry(Moscow) 59:249-254.
Radomski, et al., “The Anti-Aggregating Properties of Vascular Endothelium: Interactions Between Prostacyclin and Nitric Oxide”,Br. J. Pharmac.639-646 (1987).
Raveh et al., 1999,Anesthesiology 91(supplement): Abstract No. A713.
Rossaint et al., “Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome,”New England Journal of Medicine328:399-405 (1993).
Sellden, et al., “Inhalation of Nitric Oxide Reduced Pulmonary Hypertension after Cardiac Surgery in a 3.2-kg Infant”,Anesthesiology78(3): 577-80 (Mar., 1993).
Stamler, et al., “S-Nitrosylation of Proteins with Nitric Oxide: Synthesis and Characterization of Biologically Active Compounds”Proc. Natl. Acad. Sci. USA89: 444-448 (Jan. 1992).
Ullrich et al., “Hypoxic Pulmonary Blood Flow Redistribution and Arterial Oxygenation in Endotoxin-Challenged NOS2-Deficient Mice,”J. Clin. Invest.104:1421-1429 (1999).
Ullrich et al., “N-Acetylcysteine Partially Preserves Hypoxic Pulmonary Vasoconstriction (HPV) in Endotoxin Challenged Mice,”Am. J. Respiratory and Critical Care Medicine161:A628 (abstr.).
Weimann et al., “Congenital NOS2 Deficiency Protects Mice from LPS-Induced Hyporesponsiveness to Inhaled Oxide,”Anesthesiology91:1744-1753 (1999).
Xia et al., “Superoxide and Peroxynitrite Generation from Inductible Nitric Oxide Synthase in Macrophages,”Proc. Natl. Acad. Sci94:6954-6958 (1997).
Albert, George P., et al., “Superoxide dismutase as an adjunctive therapy for inhaled nitric oxide,”Pediatric Research,vol. 43, No. 4, Part 2, 1998, p. 272A, Abstract 1594.
Fischer, S.R., et al., “Nitric Oxide Synthase Inhibition Restores Hypoxic Pulmonary Vasconstriction in Sepsis,”American Journal of Respiratory and Critical Care Medicine,vol. 156, No. 3 Pt. 1, 1997, pp. 833-839.
Goetz, A.E., et al., “Direct Measurement of the Effects of Nitric Oxide on Hypoxic Pulmonary Vasoconstriction (HPV) in Pulmonary Arterioles and Venules,”Anesthesiology,vol. 85, No. 3A, 1996, p. A572.
Ichinose, F., et al., “Attenuation of Hypoxic Pulmonary Vasoconstriction by Endotoxemia Requires 5-Lipoxygenase in Mice,”Circulation Research,vol. 88, No. 8, Oct. 2001, pp. 832-838.
Ichinose, F., et al., “Impairment of Hypoxic Pulmonary Vasoconstriction By Endotoxemia Requires 5-Lipoxygenase in Mice”,Circulation,vol. 102, No. 18 Supplement, 2000, Abstract 1810.
Nader, N.D., et al., “High-dose nitric oxide inhalation increases lung injury after gastric aspiration,”Anesthesiology,vol. 91, No. 3, 1999, pp. 741-749.
Robbins, Carolyn G., et al., “Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and h
Bloch Kenneth D.
Ichinose Fumito
Zapol Warren M.
Fish & Richardson P.C.
Leith Patricia
The General Hospital Corporation
LandOfFree
Enhancing therapeutic effectiveness of nitric oxide inhalation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancing therapeutic effectiveness of nitric oxide inhalation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing therapeutic effectiveness of nitric oxide inhalation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3444630